Search
for
Sort by
Research 121–150 of 1000+
- Minoxidil in severe hypertension: Value when conventional drugs have failed
- POLYCYSTIC OVARY SYNDROME: PATHOGENESIS, TREATMENT AND SECONDARY ASSOCIATED DISEASES
- What does the research say about androgen use and cerebrovascular events?
- Liposome-based drug delivery systems for skin wound healing: a promising drug delivery strategy
- Drugs that affect autonomic functions or the extrapyramidal system
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Effects of anticonvulsant drugs on chromosomes.
- Severe cutaneous adverse reactions to drugs
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Drug-Induced Skin, Nail and Hair Disorders
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- DRUG‐ASSOCIATED ALOPECIA
- Drug-induced acne
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Network-Based Drug Repositioning: Approaches, Resources, and Research Directions
- Male pattern baldness and its association with coronary heart disease: a meta-analysis
- Hair growth-modulation by adrenergic drugs
- Psychoactive drugs and skin
- Lifestyle Drugs
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Cutaneous Reactions to Drugs
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Dermatological drugs, topical agents, and cosmetics
- Nurses' Drug Alert
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Novel drugs of United States Food and Drug Administration approved in 2024
- Drug Repurposing Patent Applications July–September 2025
- New drugs: Agalsidase beta
- Drug Information Analysis Service